Katherine Green - Feb 02, 2024
Most opposed patents of 2023
Multiple sclerosis therapies are the subject of two of the most opposed patents of 2023. Novartis’ EP2959894 is notable from a patent attorney perspective not only because it’s the subject of 23 oppositions, but also because it contains only about three pages of text and has just one claim. While...
Most opposed patents of 2022
As with CRISPR, patents directed to Nobel Prize-winning technologies..
Eight days – the longest ever opposition hearing at the EPO?
The EPO Opposition Division just issued its decision on European..
Most opposed patents of 2021
When we reviewed our list of the most opposed European patents of..
A guide to EPO opposition proceedings by videoconference
EPO oppositions by videoconference only became possible relatively..
Mewburn Ellis: top tier firm Legal 500 2022
Most opposed patents of 2020
Every year at the EPO about 3000-4000 patents are opposed. This..
Nobel Prize in Chemistry awarded for CRISPR "genetic scissors"
In 2012, Jennifer Doudna and Emmanuelle Charpentier published their ..
Mewburn Ellis: top tier firm Legal 500 2021
We are delighted to be ranked top tier for our patent practice in the..
Most Opposed Patents of 2019
The four thousand or so European patents that are opposed every year..
EPO streamlining: the opposition timeline tightens
Our analysis of patent oppositions has revealed that early action has..
EPO oppositions: Nine key questions answered
Mewburn Ellis has dug deep into a decade of EPO life sciences'..
Meet The Team: Katherine Green, Partner, European Patent Attorney
As part of our 'meet the team' series, we talk to Katherine Green..
Oppositions - a case to remember. Flexibility around added matter
Case 2 – T 0099/13 (EPO Board of Appeal, 14 January 2016)
The..